This 2007 study investigated the impact of chronic lithium administration on memory in rats. Over 30 days, rats received daily intraperitoneal injections of lithium chloride (2 mmol/kg) or saline. In T-maze alternation tasks, lithium-treated rats demonstrated significantly higher accuracy at 30- and 45-second delays compared to controls, indicating enhanced spatial
This 2003 review critically evaluates the efficacy of several nonprescription compounds marketed as memory enhancers, including phosphatidylserine (PS), phosphatidylcholine (PC), citicoline, piracetam, vinpocetine, acetyl-L-carnitine (ALC), and antioxidants like vitamin E. While animal studies suggest potential cognitive benefits, human clinical trials yield inconsistent and modest results. For instance, PS shows limited
This review investigates cotinine, a non-toxic metabolite of nicotine, as a potential treatment for Alzheimer’s disease (AD). Preclinical studies have shown that cotinine enhances memory, reduces amyloid-beta (Aβ) pathology, and mitigates tau-related neurotoxicity in animal models. Mechanistically, cotinine appears to modulate α7 nicotinic acetylcholine receptors (α7nAChRs), activate the Akt signaling
This 1981 study investigated the combined effects of choline and piracetam on memory and cholinergic function in aged Fischer 344 rats. Rats administered 100 mg/kg of both choline and piracetam showed significantly enhanced retention in a passive avoidance task compared to those given either compound alone. The combination therapy was
This randomized controlled trial assessed the cognitive effects of a very low-carbohydrate (ketogenic) diet in 23 older adults with mild cognitive impairment (MCI). Over six weeks, participants following the ketogenic diet exhibited significant improvements in verbal memory performance compared to those on a high-carbohydrate diet. The ketogenic group also experienced
This 1983 clinical trial evaluated the effects of oral physostigmine and lecithin on memory in eight patients with early Alzheimer’s disease. Six patients showed improvements in total recall and long-term retrieval, with reduced intrusions. Optimal physostigmine doses were 2.0 or 2.5 mg. A double-blind crossover trial confirmed these findings, correlating
This review examines various botanicals and phytochemicals, such as Ginkgo biloba, resveratrol, epigallocatechin-3-gallate, L-theanine, Bacopa monnieri, and curcumin, and their potential effects on cognitive decline. The compounds show promise in improving memory, supporting neuroprotection, and reducing inflammation and oxidative stress, all of which may help manage cognitive impairment and related
This randomized, double-blind, placebo-controlled trial examined the effects of citicoline supplementation (500 mg/day for 12 weeks) on memory function in 100 healthy older adults (ages 50-85) with age-associated memory impairment (AAMI). The citicoline group showed significant improvements in episodic memory (p=0.0025) and overall memory performance (p=0.0052) compared to the placebo.
This study investigates the effects of methylene blue on spatial memory retention in rats with cytochrome oxidase inhibition, which impairs memory. Methylene blue was found to restore memory retention by improving mitochondrial function, suggesting its potential to treat neurodegenerative diseases. The study provides evidence that methylene blue enhances memory by
This animal study investigated methylene blue’s (MB) impact on memory enhancement in rats. Post-training administration of MB (1 mg/kg) over three days led to significant improvement in discrimination learning, with MB-treated rats showing approximately 70% higher brain cytochrome c oxidase activity compared to controls. These findings suggest MB enhances memory
